Empagliflozin vs Osimertinib

## Empagliflozin vs Osimertinib: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Osimertinib**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Osimertinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Osimertinib — C28H33N7O2.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Osimertinib — 499.6050 g/mol.

**Type**: Empagliflozin — Small molecule; Osimertinib — Small molecule.